Clinical Research Directory
Browse clinical research sites, groups, and studies.
Single High-dose Brachytherapy for Giant Osteosarcoma Masses
Sponsor: Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Summary
This study is a prospective, single-arm, phase II, single-center study. Patients with locally unresectable giant osteosarcoma masses who meet the criteria are enrolled in the experimental group, and all patients receive a single dose of 10Gy of implantable brachytherapy. Record treatment-related acute events during and after treatment. Follow up on survival and local control after treatment ends, marking the end of the trial treatment.
Official title: The Therapeutic Effect of Single High-dose Brachytherapy for Locally Inoperable and Metastatic Giant Osteosarcoma Masses
Key Details
Gender
All
Age Range
12 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
16
Start Date
2024-08-30
Completion Date
2027-06-30
Last Updated
2024-08-07
Healthy Volunteers
No
Conditions
Interventions
brachytherapy
Patients with locally unresectable giant osteosarcoma masses who meet the criteria are enrolled in the experimental group, and all patients receive a single dose of 10Gy of implantable brachytherapy. Record treatment-related acute events during and after treatment. Follow up on survival and local control after treatment ends, marking the end of the trial treatment.